Above And Beyond Therapeutic Services Llc - Medicare Primary Care in Annandale, MN

Above And Beyond Therapeutic Services Llc is a medicare enrolled primary clinic (Clinic/center) in Annandale, Minnesota. The current practice location for Above And Beyond Therapeutic Services Llc is 990 Elm St E, Annandale, Minnesota. For appointments, you can reach them via phone at (320) 221-2674. The mailing address for Above And Beyond Therapeutic Services Llc is 7044 Rockwood Ave Nw, South Haven, Minnesota and phone number is (320) 221-2674.

Above And Beyond Therapeutic Services Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1447980149. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (320) 221-2674.

Contact Information

Above And Beyond Therapeutic Services Llc
990 Elm St E
Annandale
MN 55302-9416
(320) 221-2674
Not Available

Primary Care Clinic Profile

Full NameAbove And Beyond Therapeutic Services Llc
SpecialityClinic/Center
Location990 Elm St E, Annandale, Minnesota
Authorized Official Name and PositionLaura Scheer (OWNER)
Authorized Official Contact3202212674
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Above And Beyond Therapeutic Services Llc
7044 Rockwood Ave Nw
South Haven
MN 55382-3854

Ph: (320) 221-2674
Above And Beyond Therapeutic Services Llc
990 Elm St E
Annandale
MN 55302-9416

Ph: (320) 221-2674

NPI Details:

NPI Number1447980149
Provider Enumeration Date06/15/2022
Last Update Date06/15/2022

Medicare PECOS Information:

Medicare PECOS PAC ID4880078393
Medicare Enrollment IDO20220901002147

News Archive

Nanoparticles for non-invasive photodynamic therapy of deep cancer

National University of Singapore researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of treating deep cancer. Led by Associate Professor Zhang Yong, the team has so far, proven that their technology could inhibit tumour growth and control gene expression in mice. This is a world's first for the use of nanoparticles for non-invasive photodynamic therapy of deep cancer.

Long-term use of opioid prescriptions by veterans

Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Elsevier selected to publish Journal of Obstetrics and Gynaecology Canada

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the Society of Obstetricians and Gynaecologists of Canada to publish its journal, Journal of Obstetrics and Gynaecology Canada, as of January 2016.

Positive results from Alkermes' ALKS 5461 phase 1/2 study on MDD

Alkermes plc today presented positive results from the phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression, in an oral session at the 52nd Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting in Phoenix.

Researchers develop new tool to simulate the impact of SARS-CoV-2 strains and vaccines

The MOMAT research group from Universidad Complutense de Madrid has worked with Universidad de Almería, to develop a mathematical model that simulates the impact of SARS-CoV-2 strains and vaccines together, combined with many other biological and social processes in the propagation of COVID-19.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Above And Beyond Therapeutic Services Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1447980149NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261Q00000XClinic/center (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Above And Beyond Therapeutic Services Llc acts as a billing entity for following providers:
Provider NameLaura Scheer
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1538816954
PECOS PAC ID: 5799169207
Enrollment ID: I20220901002404

News Archive

Nanoparticles for non-invasive photodynamic therapy of deep cancer

National University of Singapore researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of treating deep cancer. Led by Associate Professor Zhang Yong, the team has so far, proven that their technology could inhibit tumour growth and control gene expression in mice. This is a world's first for the use of nanoparticles for non-invasive photodynamic therapy of deep cancer.

Long-term use of opioid prescriptions by veterans

Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Elsevier selected to publish Journal of Obstetrics and Gynaecology Canada

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the Society of Obstetricians and Gynaecologists of Canada to publish its journal, Journal of Obstetrics and Gynaecology Canada, as of January 2016.

Positive results from Alkermes' ALKS 5461 phase 1/2 study on MDD

Alkermes plc today presented positive results from the phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression, in an oral session at the 52nd Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting in Phoenix.

Researchers develop new tool to simulate the impact of SARS-CoV-2 strains and vaccines

The MOMAT research group from Universidad Complutense de Madrid has worked with Universidad de Almería, to develop a mathematical model that simulates the impact of SARS-CoV-2 strains and vaccines together, combined with many other biological and social processes in the propagation of COVID-19.

Read more Medical News

› Verified 2 days ago

News Archive

Nanoparticles for non-invasive photodynamic therapy of deep cancer

National University of Singapore researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of treating deep cancer. Led by Associate Professor Zhang Yong, the team has so far, proven that their technology could inhibit tumour growth and control gene expression in mice. This is a world's first for the use of nanoparticles for non-invasive photodynamic therapy of deep cancer.

Long-term use of opioid prescriptions by veterans

Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Elsevier selected to publish Journal of Obstetrics and Gynaecology Canada

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the Society of Obstetricians and Gynaecologists of Canada to publish its journal, Journal of Obstetrics and Gynaecology Canada, as of January 2016.

Positive results from Alkermes' ALKS 5461 phase 1/2 study on MDD

Alkermes plc today presented positive results from the phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression, in an oral session at the 52nd Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting in Phoenix.

Researchers develop new tool to simulate the impact of SARS-CoV-2 strains and vaccines

The MOMAT research group from Universidad Complutense de Madrid has worked with Universidad de Almería, to develop a mathematical model that simulates the impact of SARS-CoV-2 strains and vaccines together, combined with many other biological and social processes in the propagation of COVID-19.

Read more News

› Verified 2 days ago


Clinic/Center in Annandale, MN

Allina Health Annandale Clinic
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 440 Elm St E, Annandale, MN 55302
Phone: 320-274-3744    Fax: 320-274-8194

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.